Hologic, Inc.
Free
No email, no account, no signup.
Pulling latest news for Hologic, Inc.…
Bull
Bear
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report –
Order analysis – $4.99 $1.25
Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Type
Biotech
Sector
Medical technology, women's health
Market sentiment
Social sentiment is mostly neutral to slightly positive: attention centers on the cash payout, uncertainty around the CVR earn-out, and reduced transparency post-delisting.
Why NEUTRAL ?
Post-take-private there is no public equity to trade; for former shareholders the remaining value driver is the CVR and its revenue conditions. The appropriate stance is therefore 'review' (monitor) rather than buy/sell, focusing on the likelihood of Breast Health meeting FY2026–FY2027 targets.
- Monitor/evaluate CVR exposure (if applicable) and track any updates on Breast Health revenue performance; no public share position can be initiated after delisting.
We're already tracking Hologic, Inc. — here are the latest events we've registered
Recent News
- On April 7, 2026, Blackstone and TPG completed the acquisition of Hologic and the shares were delisted from Nasdaq. Shareholders received $76 per share in cash plus a non-transferable CVR worth up to $3 depending on Breast Health revenue targets in FY2026–FY2027. Joe E. Almeida became CEO; as a private company, disclosure is expected to be reduced, and OCC adjusted listed options to cash settlement.
Want to know how this news affects Hologic, Inc.? Order the analysis.
Order analysis – Dilution Risk
Assessment: Low
Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Sources: news, filings, market data, and investor forums
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Hologic, Inc. will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.